Quoin Pharmaceuticals, Ltd. - ADR
News
Quoin Pharmaceuticals announces insider share purchases
Seeking Alpha - Healthcare Quoin Pharmaceuticals announces insider share purchases...\n more…
Quoin Pharmaceuticals Announces Insider Share Purchases by Co-Founders CEO and COO
Globe Newswire Purchases Signal Leadership Confidence and Commitment to CompanyASHBURN, Va., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals (NASDAQ: QNRX), a clinical stage, specialty pharmaceutical...\n more…
Maxim Group Sticks to Their Buy Rating for Quoin Pharmaceuticals (QNRX)
TipRanks Financial Blog Maxim Group analyst Naz Rahman reiterated a Buy rating on Quoin Pharmaceuticals (QNRX - Research Report) yesterday. The company's shares opened tod...\n more…
Quoin Pharmaceuticals Provides Corporate Update and Announces Second Quarter 2024 Financial Results
Globe Newswire Quoin Broadens Product Portfolio through Research Agreement with University College Cork, Ireland Company Expands On-going Clinical Trials in Netherton Syndrome to Include International Sites...\n more…
Quoin Pharmaceuticals to Initiate Clinical Study for Peeling Skin Syndrome
Globe Newswire Peeling Skin Syndrome is a rare autosomal disease with no approved treatment or cure Initial clinical site and pediatric patient identified in New Zealand Company actively evaluating opening...\n more…